METAPLASTIC BREAST CARCINOMA
Clinical trials for METAPLASTIC BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METAPLASTIC BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METAPLASTIC BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: METAPLASTIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New hope for rare breast cancer: triple-drug combo enters phase 2 trial
Disease control Recruiting nowThis study tests a new combination of drugs (alpelisib, L-NMMA, and chemotherapy) in people with a rare and aggressive type of breast cancer called metaplastic breast cancer that has spread or cannot be removed by surgery. The goal is to see if the combination is safe and can shr…
Matched conditions: METAPLASTIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated May 17, 2026 00:47 UTC